COVID-19
| 1 min read
“The COVID-19 pandemic could be an opportunity for the companies pursuing the development of gene therapies, as few products are in development to fight the viral illness.”
Alessio Brunello of GlobalData
Alessio Brunello of GlobalData
| 3 min read
To be clear, any adverse event is always one too many. But in the real world, these things happen and often through no intrinsic fault of the therapeutic intervention
| 3 min read
Genomenon and BC Platforms seek to combine their tech platforms to boost genomic research
| 3 min read
Topline data from a recent Eli Lilly clinical trial indicate that tirzepatide led to superior A1C and body weight reductions from baseline compared to injectable semaglutide in adults with type 2 diabetes.
Available on Demand
LIVE April 28th at 2:30 PM ET.
In this webinar, Adam Green will discuss vaccine separation and key considerations for optimizing filtration and membrane separation-based processes.
In this webinar, Adam Green will discuss vaccine separation and key considerations for optimizing filtration and membrane separation-based processes.
| 4 min read
A team of physicians performed double duty as scientists and research subjects for a recent study that cautions against prematurely resuming social activities during the pandemic.
| 3 min read
The pandemic has not been good to us, but some good things might come out of it
| 4 min read
Highlights of some of the most recent new R&D tools to curb the pandemic
| 4 min read
A study published in Nature Medicine points to saliva’s role in SARS-CoV-2 transmission
